Pacific Biosciences of California, Inc. Announces Second Quarter 2020 Financial Results
MENLO PARK, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020.Total revenue for the second quarter of 2020 was $17.1 million, compared with $24.6 million for the same period of 2019. Instrument revenue for the second quarter of... Read more